Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-12-025549)

Filing Details

Accession Number:: 0001209191-12-025549
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-05-02 17:54:17
Reporting Period:: 2012-05-01

Filing Date:: 2012-05-02
Accepted Time:: 2012-05-02 17:54:17
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1088856	Corcept Therapeutics Inc	CORT	Pharmaceutical Preparations (2834)	770487658

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1286208	L Robert Roe	C/O Corcept Therapeutics 149 Commonwealth Drive Menlo Park CA 94025	President And Secretary	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2012-05-01	10,000	$1.19	10,000	No	4	M	Direct
Common Stock	Disposition	2012-05-01	10,000	$3.69	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock option	Disposition	2012-05-01	10,000	$0.00	10,000	$1.19

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
150,000		2019-03-26	No	4	M	Direct

Footnotes

Represents the weighted average sale price for the entire number of shares sold. The sale prices range from $3.66 to $3.72 per share. Full information on the numbers of shares sold at each sale price is available upon request.
Fully exerciseable.